| Literature DB >> 31556774 |
Michael G Z Ghali1,2, Justin Davanzo2, Madeline Leo2, Elias Rizk2.
Abstract
Posterior reversible encephalopathy syndrome (PRES) is well-described in adults, but has been reported with relative rarity in children, usually occurring in the context of chemotherapy for acute leukemia. Pathogenesis involves perturbed cerebral autoregulation leading to vasogenic edema predominantly affecting the parieto-occipital white matter, though involvement of the frontal and temporal lobes, as well as posterior fossa, is also described. We review the literature on the pathophysiology, diagnosis, and management of PRES in pediatric patients.Entities:
Keywords: ALL; AML; PRES; chemotherapy; hypertension; leukemia; pathogenesis; reversible posterior leukoencephalopathy syndrome
Year: 2019 PMID: 31556774 DOI: 10.1080/10428194.2019.1594210
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022